Logo - springer
Slogan - springer

Birkhäuser - Contact | Prof. Michael J. Parnham, Ph.D., C.Biol.MRSB, FBPhS

Prof. Michael J. Parnham, Ph.D., C.Biol.MRSB, FBPhS

Prof. Michael J. Parnham, Ph.D., C.Biol.MRSB, FBPhS

Pharmacology Consultant
Frankfurt am Main
Germany

mjparnham@yahoo.co.uk

Born in London, UK, Michael Parnham studied Pharmacology at Chelsea (now King's) College, gaining practical experience in the department of the subsequent Nobel Prize winner, John R. Vane, at the Royal College of Surgeons. With a PhD from Bristol University (1976), he carried out postdoctoral research on prostaglandins and chronic inflammation with Ivan Bonta at Erasmus University Rotterdam, The Netherlands. This led to the award of the Goslings Prize for research on antirheumatic therapy and the co-founding with Ivan Bonta and Kay Brune of the European Workshop on Inflammation, of which Dr. Parnham was secretary for many years.
From 1980, he spent a decade in anti-inflammatory research with A. Nattermann and subsequently Rhone-Poulenc in Cologne, Germany. During this time he was Co-Editor of AGENTS AND ACTIONS and he and his colleagues received in 1990 the Prix Galien Germany for development of a novel organoselenium approach to anti-inflammatory therapy. In the same year, Dr. Parnham established a consultancy in Bonn - where he also presided as Managing Editor (1992-2013) over the transformation of AGENTS AND ACTIONS into INFLAMMATION RESEARCH - and started teaching immunopharmacology in the Pharmacy Faculty at Goethe University Frankfurt.
Appointed Professor in 1998, Dr. Parnham moved to Zagreb, Croatia to establish laboratories in pharmacology and toxicology at PLIVA Pharmaceuticals, subsequently becoming Senior Scientific Advisor. Here, he helped develop biosimilar agents and the team elucidated the immunomodulatory effects of macrolide antibiotics. Following the acquisition by GSK in 2006, he was Director of Preclinical Discovery working on novel anti-inflammatory macrolides. From 2012 to 2019, Prof.Parnham built up preclinical research in the Fraunhofer Institute of Molecular Biology & Applied Ecology IME, Branch for Translational Medicine and Pharmacology, in Frankfurt am Main. He is co-editor of the monograph series PROGRESS IN INFLAMMATION RESEARCH, co-editor of MILESTONES IN DRUG THERAPY and of the textbook PRINCIPLES OF IMMUNOPHARMACOLOGY. He is also Editor-in-Chief of the Springer Reference COMPENDIUM OF INFLAMMATORY DISEASES. Dr. Parnham has published and lectured extensively and organised symposia on various aspects of immunopharmacology and anti-inflammatory therapy and in 2015, received a Lifetime Achievement Award from the International Association of Inflammatory Societies (IAIS). He is a scientific advisor to several companies.